MedTrace Logo

PICC Asymptomatic Thrombosis Study: A Pilot Study

NCT04920929 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2022-11-29

Study results available
· View outcomes & findings →

Summary

The study purpose is to perform a preliminary, comparative evaluation of the Hydrophilic Biomaterial technology to confirm the performance of the catheter, by using UltraSound technology in-vivo.

Conditions

  • Peripheral ICC

Interventions

DEVICE

Hydrophilic Biomaterial

PICC made out of a Hydrophilic Biomaterial

DEVICE

Thermoplastic Polyurethane

PICC made out of a thermoplastic polyurethane material

Sponsors & Collaborators

  • Access Vascular Inc

    lead INDUSTRY

Principal Investigators

  • Amit Bahl, MD · Beaumont Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-15
Primary Completion
2021-10-07
Completion
2021-10-07
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04920929 on ClinicalTrials.gov